
Grove AI Revolutionizes Clinical Trial Enrollment with AI
News Summary
Grove AI, co-founded by Tran Le and Sohit Gatiganti, is transforming the clinical trial enrollment process through its generative AI agent called Grace. This AI-driven solution significantly reduces the time required for patient enrollment, addressing common challenges such as bureaucratic hurdles and outdated systems. Since its inception eight months ago, Grove AI has interacted with over 70,000 patients and scheduled 7,000 in-person appointments. The startup has secured $4.9 million in seed funding from investors including A*, Afore Capital, LifeX Ventures, and Pear VC. Grove AI’s technology not only simplifies trial enrollment but also has the potential to revolutionize patient data management, providing a competitive edge in the burgeoning market of AI-driven healthcare solutions.




